Given the incomplete current understanding of these neoplasms, we suggest that all uterine mesenchymal neoplasms with overlapping morphology and immunophenotype between endometrial stromal and smooth muscle neoplasms undergo molecular testing to identify a KAT6B/A::KANSL1 fusion. The gene discussed is KANSL1; the disease is smooth muscle tumor.